Dr. Keith Crawford

Dr. Keith Crawford

Director of Clinical Trials and Patient Education

Director of Clinical Trials and Patient Education

PHEN

Dr. Keith Crawford joined PHEN in 2019.  As Director of Clinical Trials and Patient Education, he is responsible for implementing programs in these areas as well as working with patients and PHEN partners.

Dr. Crawford has more than 20 years of experience in the Life Sciences and completed his graduate and post-graduate training at Harvard Medical School where he developed competencies in the area of genomics, proteomics, immunology, microbiology, infectious diseases, and regenerative medicine.

During his post-doctoral training, Keith was selected by the Robert Wood Johnson Foundation as a Harold Amos Fellow. His work in the field of immunology caught the eye of the Department of Defense where he received funding to develop antidotes for chemical and biological weapons exposure as well as create a high throughput platform for the detection of biological weapons and emerging infectious agents.

After completing this directive, Dr. Crawford became the Director of the Center for Molecular Orthopedics at Brigham and Women’s Hospital. He was responsible for leading research efforts at the center, which gave rise to the discovery of a novel population of early lineage adult stem cells.  Dr. Crawford and his colleagues were responsible for the preclinical studies, which laid the foundation for a spinal fusion therapeutic. 

Dr. Crawford is a graduate of Prairie View University, the University of Texas Medical School in Houston (Medical Doctorate), and Harvard University (Doctor Philosophy) where he studied cell biology and immunology.

Dr. J. Jacques Carter

Dr. J. Jacques Carter

Assistant Professor

Assistant Professor

Harvard Medical School

Dr. Jacques Carter currently serves as an attending physician at the Beth Israel Deaconess Medical Center in Boston and is an assistant professor of medicine at Harvard Medical School. ‍‍From 2005 to 2014, he also served as the Medical Director of the Prostate Cancer Screening and Education Program at the Dana-Farber Cancer Institute in Boston. Dr. Carter serves as a medical advisor for PHEN and a member of its board of directors.

Dr. Carter has been active in a number of civic and community organizations, including past board president of the Family Service of Greater Boston and past chair of the Brookline Advisory Council on Public Health.

He has earned degrees from Howard and George Washington Universities and received his medical degree from Georgetown University in Washington, D.C. Dr. Carter completed his residency training in Internal Medicine at Beth Israel Deaconess Medical Center in Boston. Then, Dr. Carter completed a graduate program at the Harvard School of Public Health where he received his Master of Public Health (MPH) degree.

He then completed a clinical fellowship in Primary Care Medicine at the Massachusetts General Hospital. Since completing his training, Dr. Carter has held a number of clinical and administrative positions including medical directorships of several local and national healthcare organizations.

As former director of one of the major clinical clerkships, he now serves as a teacher, advisor, and mentor for students at Harvard College, Harvard Medical School, and the School of Public Health. He regularly gives talks on medical and health-related topics to community groups and students throughout the greater Boston area. He also lectures nationally and internationally on medical and public health topics. Dr. Carter serves as a medical consultant and resource for members of the print and electronic media.

Mr. Thomas A. Farrington

Mr. Thomas A. Farrington

President and Founder

President and Founder

PHEN

Thomas Farrington founded the Prostate Health Education Network (PHEN) in 2003 after receiving treatment for prostate cancer in 2000 and publishing his first book Battling The Killer Within in 2001. Under Mr. Farrington’s leadership, PHEN is recognized as the leading prostate cancer education and advocacy organization with national programs and initiatives focused on the needs of African Americans.

A key foundation for PHEN’s success is its national network of prostate cancer survivors and their loved ones who support the organization’s efforts within their communities. PHEN partners with hundreds of churches across the nation to bring education and awareness programs into their communities and recruit local prostate cancer medical specialists as educators for these events.

PHEN also makes extensive use of online programming to reach and support individual educational needs. Mr. Farrington’s background is in Information Technology.  Farrington currently serves as a member of the National Comprehensive Cancer Network’s (NCCN) Prostate Cancer Treatment Guidelines Panel and the NCCN Prostate Cancer Early Detection Guidelines Panel. He serves as a trustee of the Dana-Farber Cancer Institute and as an advisor to a number of other healthcare organizations and programs. Mr. Farrington received a B.S. in Electrical Engineering from North Carolina Agricultural and Technical State University in 1966.